Celtaxsys gains US clearance for Phase 2 trial of acebilustat in patients with cystic fibrosis
7 July 2015 | By
Celtaxsys has gained clearance from the US FDA to begin a Phase 2 clinical trial of acebilustat in adult patients with cystic fibrosis (CF) in the US...